High-performance low field MRI enables visualization of persistent pulmonary damage after COVID-19.
High-performance low field MRI enables visualization of persistent pulmonary damage after COVID-19.
复制标题
DOI:
10.1016/j.mri.2020.11.004
复制
发表时间:
2021-03
影响因子:
2.5
通讯作者:
Bickelhaupt S
中科院分区:
文献类型:
--
作者:
Heiss R;Grodzki DM;Horger W;Uder M;Nagel AM;Bickelhaupt S
The outbreak of coronavirus disease 2019 (COVID-19) with the origin of the spread assumed to be located in Wuhan, China, began in December 2019, and is continuing until now. With the COVID-19 pandemic showing a progressive spread throughout the countries of the world, there is emerging interest for the potential long-term consequences of suffering from a COVID-19 pneumonia. Imaging plays a central role in the diagnosis and management of COVID-19 pneumonia, with chest X-ray examinations and computed tomography (CT) being undoubtedly the modalities most widely used, allowing for a fast and sensitive detection of infiltration patterns associated with COVID-19 pneumonia. For a better understanding of underlying pathomechanisms of pulmonary damage, longitudinal imaging series are warranted, for which CT is of limited usability due to repeated exposure of X-rays. Recent advances in MRI suggested that high-performance low-field MRI might represent a valuable method for pulmonary imaging without the need of radiation exposure. However, so far, low-field MRI has not been applied to study pulmonary damage after COVID-19 pneumonia. We present a case report of a patient who suffered from COVID-19 pneumonia using 0.55 T MRI for follow-up examinations three months after initial infection. Low-field MRI enables a precise visualization of persistent pulmonary changes including ground-glass opacities, which are consistent with CT performed on the same day. Low-field MRI seems to be feasible in the detection of pulmonary involvement in patients with COVID-19 pneumonia and may have the potential for repetitive lung examinations in monitoring the reconvalescence after pulmonary infections.
登录
查看更多内容
影响因子:
19.7
作者:
Campbell-Washburn, Adrienne E.;Ramasawmy, Rajiv;Balaban, Robert S.
通讯作者:
Balaban, Robert S.
影响因子:
4.4
作者:
Yang, Shuyi;Zhang, Yunfei;Shan, Fei
通讯作者:
Shan, Fei
影响因子:
5.8
作者:
Huang, Yiying;Tan, Cuiyan;Liu, Jing
通讯作者:
Liu, Jing
影响因子:
4.4
作者:
Balasch, Anke;Metze, Patrick;Rasche, Volker
通讯作者:
Rasche, Volker
影响因子:
19.7
作者:
Pan, Feng;Ye, Tianhe;Zheng, Chuansheng
通讯作者:
Zheng, Chuansheng